00512 GRAND PHARMA
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.22X | Oper Margin | 24.8% |
---|---|---|---|
LT Debt/Equity | 7.9% | Net Margin | 21.2% |
Total Debt/Equity | 27.0% | Return on Equity | 15.0% |
Price/Book | 2.01X | Return on Assets | 9.9% |
(HKD 9.310) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 2,468.38 | 1,880.00 | 2,079.42 | 2,402.56 | 1,792.66 |
---|---|---|---|---|---|
Net Profit Growth (%) | +31.3 | -9.6 | -13.5 | +34.0 | +55.8 |
Earnings Per Share (HKD) | 0.705 | 0.536 | 0.587 | 0.677 | 0.52 |
Earnings Per Share Growth (%) | +31.5 | -8.7 | -13.3 | +30.2 | +48.2 |
Dividend Per Share (HKD) | 0.260 | 0.260 | 0.140 | 0.110 | 0.110 |
P/E* (X) | 13.21 | 17.37 | 15.86 | 13.75 | 17.89 |
Yield (%) | 2.79 | 2.79 | 1.50 | 1.18 | 1.18 |
Dividend Share (%) | 36.88 | 48.51 | 23.85 | 16.24 | 21.14 |
Book NAV (HKD) | 4.641 | 4.270 | 3.984 | 3.773 | 3.166 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(HKDMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 6,107 | 6,047 | +1.0 | 5,989 |
Operating Result | 1,290 | 1,813 | -28.8 | 1,333 |
Associates | 57.944 | 18.816 | +208.0 | -6.811 |
Profit Before Taxation | 1,348 | 1,832 | -26.4 | 1,326 |
Taxation | 174.023 | 244.175 | -28.7 | 268.926 |
Profit /( Loss) After Taxation | 1,174 | 1,588 | -26.1 | 1,057 |
Minority Interests | 4.851 | 29.762 | -83.7 | 27.417 |
Net Profit | 1,169 | 1,558 | -25.0 | 1,029 |
Earnings Per Share () | 0.3338 | 0.4441 | -24.8 | 0.2912 |
Announcement Date | 2025-08-19 | 2024-08-19 | NA | 2023-08-10 |
* Annualised
Last Update Time: 2025-09-08 21:40:25